10 High-Yield Dividend Aristocrats That Could Be Perfect For What's Coming NextSeeking Alpha • 08/10/24
Nasdaq Sell-Off: 5 Unstoppable Stocks to Buy That Can Protect Your Principal and Grow Your Wealth in an Unpredictable MarketThe Motley Fool • 08/09/24
Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of MedicinePRNewsWire • 08/07/24
RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific ReportsAccesswire • 08/01/24
Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific ReportsAccesswire • 08/01/24
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligiblePRNewsWire • 07/30/24
Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare ConferenceBusiness Wire • 07/29/24
Pharma companies less concerned after hearing from US on negotiated prices for MedicareReuters • 07/29/24
Could Johnson & Johnson's Troubles With Talc Lawsuits Finally Be Coming to an End?The Motley Fool • 07/27/24